Fresenius Medical Care Corporation (FMS)

Currency in USD
24.84
-0.24(-0.96%)
Closed·
25.10+0.26(+1.05%)
·
FMS Scorecard
Full Analysis
High shareholder yield
FMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.8025.02
52 wk Range
18.6630.46
Key Statistics
Prev. Close
24.84
Open
24.82
Day's Range
24.8-25.02
52 wk Range
18.66-30.46
Volume
342.95K
Average Volume (3m)
367.52K
1-Year Change
30.94%
Book Value / Share
53.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FMS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.91
Upside
+24.45%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Compare FMS to Peers and Sector

Metrics to compare
FMS
Peers
Sector
Relationship
P/E Ratio
19.2x20.1x−0.6x
PEG Ratio
0.810.060.00
Price/Book
0.9x2.1x2.6x
Price / LTM Sales
0.6x0.9x3.3x
Upside (Analyst Target)
24.1%72.1%39.1%
Fair Value Upside
Unlock25.8%4.5%Unlock

Analyst Ratings

2 Buy
4 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 30.91
(+24.45% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.24%
Dividend Yield
2.29%
Industry Median 2.46%
Annualised payout
0.57
Paid unevenly
5-Years Growth
+3.71%
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
0.91 / 0.50
Revenue / Forecast
4.79B / 5.82B
EPS Revisions
Last 90 days

FMS Income Statement

People Also Watch

56.60
AAP
-0.42%
28.99
CNC
+1.76%
141.58
CRCL
-5.15%
149.73
CAH
+0.08%
16.060
JOBY
-3.43%

FAQ

What Stock Exchange Does Fresenius Medical Care ADR Trade On?

Fresenius Medical Care ADR is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Fresenius Medical Care ADR?

The stock symbol for Fresenius Medical Care ADR is "FMS."

What Is the Fresenius Medical Care ADR Market Cap?

As of today, Fresenius Medical Care ADR market cap is 14.71B.

What Is Fresenius Medical Care ADR's Earnings Per Share (TTM)?

The Fresenius Medical Care ADR EPS (TTM) is 2.24.

When Is the Next Fresenius Medical Care ADR Earnings Date?

Fresenius Medical Care ADR will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is FMS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Fresenius Medical Care ADR Stock Split?

Fresenius Medical Care ADR has split 2 times.

How Many Employees Does Fresenius Medical Care ADR Have?

Fresenius Medical Care ADR has 112445 employees.

What is the current trading status of Fresenius Medical Care ADR (FMS)?

As of 19 Aug 2025, Fresenius Medical Care ADR (FMS) is trading at a price of 24.84, with a previous close of 24.84. The stock has fluctuated within a day range of 24.80 to 25.02, while its 52-week range spans from 18.66 to 30.46.

What Is Fresenius Medical Care ADR (FMS) Price Target According to Analysts?

The average 12-month price target for Fresenius Medical Care ADR is USD30.91251605, with a high estimate of USD38.3199066 and a low estimate of USD22.99708114. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +24.45% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.